top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

UroGen Pharma Ltd. - Ordinary Shares (NQ:URGN)

37.23 -3.47 (-8.53%)
Delayed Quote Updated: 1:48 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UroGen Pharma Ltd. - Ordinary Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Earnings Scheduled For March 21, 2022 ↗
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
News headline image
How To Attend UroGen Pharma Q4 2021 Earnings Conference Call ↗
UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call... 
Via Benzinga
News headline image
Earnings Outlook For UroGen Pharma ↗
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
UroGen Pharma Earnings Preview ↗
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
UroGen Pharma Q4 2021 Earnings Conference Call On March 21, 2022 At 10:00 AM ET ↗
UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call... 
Via Benzinga
News headline image
Earnings Scheduled For March 10, 2022 ↗
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
News headline image
Earnings Outlook For UroGen Pharma ↗
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
88 Biggest Movers From Yesterday ↗
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala... 
Via Benzinga
News headline image
UroGen Pharma to Participate in Panel Discussion at Cowen 42nd Annual Healthcare Conference
From UroGen Pharma Ltd.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company... 
Via Benzinga
News headline image
UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients
From UroGen Pharma Ltd.
Via Business Wire
News headline image
UroGen Announces Start of Pivotal Single-Arm Phase 3 Trial for UGN-102, an Investigational Non-Surgical Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
From UroGen Pharma Ltd.
Via Business Wire
News headline image
UroGen Pharma to Present at Upcoming Conferences
From UroGen Pharma Ltd.
Via Business Wire
News headline image
First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
From UroGen Pharma Ltd.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
Via Benzinga
News headline image
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From UroGen Pharma Ltd.
Via Business Wire
News headline image
70 Biggest Movers From Yesterday ↗
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The... 
Via Benzinga
News headline image
UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
From UroGen Pharma Ltd.
Via Business Wire
News headline image
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
News headline image
Earnings Scheduled For November 15, 2021 ↗
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to... 
Via Benzinga
News headline image
Earnings Preview: UroGen Pharma ↗
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
UroGen Pharma Announces Upcoming 2021 Conferences
From UroGen Pharma Ltd.
Via Business Wire
News headline image
UroGen Pharma Unveils New Phase 3 Development Plan for UGN-102 at Spotlight Event
From UroGen Pharma Ltd.
Via Business Wire
News headline image
UroGen Pharma to Host Virtual Spotlight Event on November 10, 2021
From UroGen Pharma Ltd.
Via Business Wire
News headline image
The Journal of Urology Publishes Results of UroGen Pharma’s Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
From UroGen Pharma Ltd.
Via Business Wire
News headline image
UroGen Pharma to Present at the 2021 Cantor Virtual Global Healthcare Conference
From UroGen Pharma Ltd.
Via Business Wire
News headline image
UroGen Pharma Presents Data Showcasing Novel Clinical Data at 2021 American Urological Association (AUA) Annual Meeting
From UroGen Pharma Ltd.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page